EphA2 Antibodies

Santa Cruz Biotechnology provides a broad selection of EphA2 monoclonal antibodies for research focused on understanding EphA2 protein functions in biological processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EphA2 is a member of the Eph receptor family, which plays a vital role in cell signaling, particularly in processes such as cell adhesion, migration, and tissue organization. EphA2 has been extensively studied in cancer progression and metastasis, making it an important target for therapeutic intervention. Research has shown that EphA2 influences multiple cellular pathways and mechanisms. Scientists continue to uncover new functions of EphA2 in both normal development and disease states. Understanding EphA2's molecular interactions and signaling cascades can provide valuable insights into potential therapeutic strategies. The extensive selection of monoclonal antibodies from Santa Cruz Biotechnology enables researchers worldwide to advance scientific understanding of EphA2's role in health and disease.